JP2021518379A5 - - Google Patents
Info
- Publication number
- JP2021518379A5 JP2021518379A5 JP2020550114A JP2020550114A JP2021518379A5 JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5 JP 2020550114 A JP2020550114 A JP 2020550114A JP 2020550114 A JP2020550114 A JP 2020550114A JP 2021518379 A5 JP2021518379 A5 JP 2021518379A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- pyrimidine
- pyrrolo
- azaspiro
- amino
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862646167P | 2018-03-21 | 2018-03-21 | |
| US62/646,167 | 2018-03-21 | ||
| PCT/US2019/022657 WO2019182924A1 (en) | 2018-03-21 | 2019-03-18 | Jak inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021518379A JP2021518379A (ja) | 2021-08-02 |
| JPWO2019182924A5 JPWO2019182924A5 (https=) | 2022-03-30 |
| JP2021518379A5 true JP2021518379A5 (https=) | 2022-03-30 |
| JP7462951B2 JP7462951B2 (ja) | 2024-04-08 |
Family
ID=67986579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020550114A Active JP7462951B2 (ja) | 2018-03-21 | 2019-03-18 | Ｊａｋ阻害剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US11365188B2 (https=) |
| EP (1) | EP3768272B1 (https=) |
| JP (1) | JP7462951B2 (https=) |
| CN (1) | CN111936144B (https=) |
| AU (1) | AU2019237991B2 (https=) |
| CA (1) | CA3093706A1 (https=) |
| WO (1) | WO2019182924A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA202092441A1 (ru) | 2016-06-07 | 2021-05-21 | Джакобио Фармасьютикалс Ко., Лтд. | Новые гетероциклические производные, применимые в качестве ингибиторов shp2 |
| KR20240026521A (ko) | 2017-03-23 | 2024-02-28 | 자코바이오 파마슈티칼스 컴퍼니 리미티드 | Shp2 억제제로서 유용한 신규한 헤테로환형 유도체 |
| CN112839935A (zh) | 2018-09-26 | 2021-05-25 | 北京加科思新药研发有限公司 | 可用作shp2抑制剂的新型杂环衍生物 |
| JP2022506682A (ja) * | 2018-11-05 | 2022-01-17 | アビスタ ファーマ ソリューションズ，インコーポレーテッド | 化合物 |
| CA3125039A1 (en) | 2019-01-23 | 2020-07-30 | Theravance Biopharma R&D Ip, Llc | Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors |
| WO2020155931A1 (zh) | 2019-01-30 | 2020-08-06 | 格格巫（珠海）生物科技有限公司 | 一种jak抑制剂及其制备方法 |
| WO2022117075A1 (zh) * | 2020-12-04 | 2022-06-09 | 广州费米子科技有限责任公司 | 氮杂并环化合物、其制备方法及其用途 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102032934B1 (ko) * | 2011-12-21 | 2019-10-16 | 지앙수 헨그루이 메디슨 컴퍼니 리미티드 | 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도 |
| MX368464B (es) | 2013-12-05 | 2019-10-02 | Pfizer | Acrilamidas de pirrolo[2,3-d]pirimidinilo, pirrolo[2,3-b]pirazinil o y pirrolo[2,3-d]piridinilo. |
| WO2015131080A1 (en) | 2014-02-28 | 2015-09-03 | Nimbus Lakshmi, Inc. | Tyk2 inhibitors and uses thereof |
| EP3180344B1 (en) * | 2014-08-12 | 2019-09-18 | Pfizer Inc | Pyrrolo[2,3-d]pyrimidine derivatives useful for inhibiting janus kinase |
| EP3248980B1 (en) | 2015-01-20 | 2023-09-06 | Wuxi Fortune Pharmaceutical Co., Ltd | Jak inhibitor |
| WO2018169700A1 (en) | 2017-03-14 | 2018-09-20 | Sunshine Lake Pharma Co., Ltd. | Substituted heteroaryl compounds and methods of use |
-
2019
- 2019-03-18 JP JP2020550114A patent/JP7462951B2/ja active Active
- 2019-03-18 CA CA3093706A patent/CA3093706A1/en active Pending
- 2019-03-18 US US16/979,455 patent/US11365188B2/en active Active
- 2019-03-18 AU AU2019237991A patent/AU2019237991B2/en active Active
- 2019-03-18 WO PCT/US2019/022657 patent/WO2019182924A1/en not_active Ceased
- 2019-03-18 EP EP19770607.0A patent/EP3768272B1/en active Active
- 2019-03-18 CN CN201980020463.5A patent/CN111936144B/zh active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021518379A5 (https=) | ||
| JP6695353B2 (ja) | Ｆｇｆｒ４阻害剤としてのホルミル化ｎ−複素環式誘導体 | |
| TWI579284B (zh) | 咪唑并吡咯啶酮化合物 | |
| JP2024522345A (ja) | ウェルナー症候群ＲｅｃＱヘリカーゼ（ＷＲＮ）の阻害に関連する疾患を治療するためのトリアゾロ－ピリミジン類似体 | |
| CN118974055A (zh) | 作为突变kras蛋白抑制剂的喹唑啉化合物及其用途 | |
| JP2013523884A5 (https=) | ||
| JP2013515070A5 (https=) | ||
| AU2017286654A1 (en) | Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases | |
| JP2025536259A (ja) | 三環式化合物及びその使用 | |
| EP3710002A2 (en) | Degraders and degrons for targeted protein degradation | |
| HRP20140770T1 (hr) | SUPSTITUIRANI SPOJEVI N-(1H-INDAZOL-4-IL)IMIDAZO[1,2-a]PIRIDIN-3-KARBOKSAMIDA KAO INHIBITORI CFMS | |
| EP4237086A1 (en) | Heterocyclic spiro compounds and methods of use | |
| CN108430993A (zh) | Tank-结合激酶抑制剂化合物 | |
| HK1248235A1 (zh) | 具有作为吲哚胺2，3-二加氧酶抑制剂活性的苯并咪唑和咪唑并吡啶亚氨代甲酰胺化合物 | |
| RU2014126750A (ru) | Ингибиторы тирозинкиназы брутона | |
| RU2013136778A (ru) | Ингибиторы гистондезацетилазы, композиции и способы их применения | |
| JP2012515737A (ja) | メトトレキサートおよびｄｈｏｄｈ阻害剤を含む組合せ剤 | |
| CN111051305A (zh) | 治疗性杂环化合物 | |
| JP2006512366A5 (https=) | ||
| KR20220028075A (ko) | 티로신 키나제 비-수용체 1 (tnk1) 억제제 및 그의 용도 | |
| JP2021514011A5 (https=) | ||
| RU2015102537A (ru) | Цианогуанидины и их применение в качестве противовирусных средств | |
| RU2006138606A (ru) | Ингибиторы киназы | |
| RU2014105177A (ru) | Новое соединение, проявляющее ингибиторную активность в отношении parp | |
| JP2003516994A5 (https=) |